9MTZ | pdb_00009mtz

L6A variant of mini-alphaA crystallin

  • Classification: CHAPERONE
  • Organism(s): Homo sapiens
  • Mutation(s): Yes 

  • Deposited: 2025-01-13 Released: 2025-07-02 
  • Deposition Author(s): Sroge, C.D., Zhu, J., Padilla, M.S.T.L., Martin, R.W.
  • Funding Organization(s): National Institutes of Health/National Eye Institute (NIH/NEI), National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)

Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 20 
  • Conformers Submitted: 
  • Selection Criteria: structures with the lowest energy 

wwPDB Validation   3D Report Full Report


This is version 1.0 of the entry. See complete history


Literature

Mini-alpha A-crystallin protects a client lens protein from catastrophic aggregation due to heat stress.

Sroge, C.Suk, J.Zhu, J.Padilla, M.S.T.L.Baca, C.F.Butts, C.T.Martin, R.W.

(2025) Protein Sci 34: e70199-e70199

  • DOI: https://doi.org/10.1002/pro.70199
  • Primary Citation of Related Structures:  
    9MTZ, 9MU0, 9MYQ

  • PubMed Abstract: 

    The clarity and refractivity of the eye lens are mediated by the highly soluble crystallin proteins. Post-translational modifications impact solubility and stability of the structural and refractive βγ-crystallins, eventually leading to cataract. Such damaged proteins are kept in solution by the holdase chaperone α-crystallins, maintaining lens transparency over decades despite the absence of protein turnover. It was previously found that a short peptide from human αA-crystallin (mini-αA-crystallin [MAAC]) retains some chaperone activity, with hydrophobic interactions hypothesized to mediate chaperone-client interactions; MAAC has been hypothesized to have β-strand structure in solution, although its conformational ensemble under these conditions has not been well-characterized. Here, we employ a combination of nuclear magnetic resonance (NMR), circular dichroism spectroscopy, dynamic light scattering, and molecular dynamics simulations to examine the behavior of MAAC in dilute solution and in combination with human γS-crystallin. Structural ensembles of two alanine variants of MAAC (I4A and L6A) show that the variants lack well-defined secondary structure, but have a preference for a bent conformation with some self-interaction. A partial alanine scan indicates that several hydrophobic residues are important for peptide solubility, also modifying the peptide's conformational ensemble. Tests of wild-type MAAC chaperone activity on thermally stressed γS-crystallin show little interaction between MAAC and the client protein below its unfolding temperature. However, MAAC does inhibit large-scale aggregation at the γS-crystallin unfolding temperature. NMR measurements indicate only weak, transient interaction with the client protein during the intermediate aggregation phase, suggesting a sharp phase transition in the MAAC-client system.


  • Organizational Affiliation
    • Department of Molecular Biology and Biochemistry, UC Irvine, Irvine, California, USA.

Macromolecules

Find similar proteins by:  Sequence   |   3D Structure  

Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Alpha-crystallin A(1-162) peptideA [auth 1]19Homo sapiensMutation(s): 1 
UniProt & NIH Common Fund Data Resources
Find proteins for P02489 (Homo sapiens)
Explore P02489 
Go to UniProtKB:  P02489
PHAROS:  P02489
GTEx:  ENSG00000160202 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP02489
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 20 
  • Conformers Submitted: 
  • Selection Criteria: structures with the lowest energy 

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Eye Institute (NIH/NEI)United StatesT32EY032448
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesR01GM144964

Revision History  (Full details and data files)

  • Version 1.0: 2025-07-02
    Type: Initial release